# | Title | Journal | Year | Citations |
---|
1 | Japanese classification of gastric carcinoma: 3rd English edition | Gastric Cancer | 2011 | 3,039 |
2 | Japanese Classification of Gastric Carcinoma – 2nd English Edition – | Gastric Cancer | 1998 | 2,184 |
3 | Japanese gastric cancer treatment guidelines 2010 (ver. 3) | Gastric Cancer | 2011 | 2,086 |
4 | Japanese gastric cancer treatment guidelines 2014 (ver. 4) | Gastric Cancer | 2017 | 2,020 |
5 | Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers | Gastric Cancer | 2000 | 1,604 |
6 | Japanese Classification of Gastric Carcinoma - 2nd English Edition - | Gastric Cancer | 1998 | 1,247 |
7 | Japanese gastric cancer treatment guidelines 2018 (5th edition) | Gastric Cancer | 2021 | 1,206 |
8 | Endoscopic resection of early gastric cancer | Gastric Cancer | 2007 | 621 |
9 | Application of artificial intelligence using a convolutional neural network for detecting gastric cancer in endoscopic images | Gastric Cancer | 2018 | 539 |
10 | Gastric cancer treatment guidelines in Japan | Gastric Cancer | 2002 | 517 |
11 | Incidence of lymph node metastasis and the feasibility of endoscopic resection for undifferentiated-type early gastric cancer | Gastric Cancer | 2009 | 440 |
12 | Gastric cancer: Asia and the world | Gastric Cancer | 2017 | 427 |
13 | HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer | Gastric Cancer | 2015 | 415 |
14 | Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry | Gastric Cancer | 2013 | 396 |
15 | Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association | Gastric Cancer | 2014 | 395 |
16 | A multicenter retrospective study of endoscopic resection for early gastric cancer | Gastric Cancer | 2006 | 393 |
17 | Diet and the risk of gastric cancer: review of epidemiological evidence | Gastric Cancer | 2007 | 379 |
18 | Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project | Gastric Cancer | 2017 | 357 |
19 | Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001–2007) | Gastric Cancer | 2018 | 346 |
20 | The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines | Gastric Cancer | 2016 | 339 |
21 | High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer | Gastric Cancer | 2010 | 335 |
22 | The epidemiology of gastric cancer | Gastric Cancer | 2002 | 316 |
23 | Safety and feasibility of laparoscopy-assisted distal gastrectomy with suprapancreatic nodal dissection for clinical stage I gastric cancer: a multicenter phase II trial (JCOG 0703) | Gastric Cancer | 2010 | 297 |
24 | Short-term surgical outcomes from a phase III study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric cancer: Japan Clinical Oncology Group Study JCOG0912 | Gastric Cancer | 2017 | 288 |
25 | New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points | Gastric Cancer | 2011 | 275 |
26 | HER2-positive gastric cancer | Gastric Cancer | 2014 | 272 |
27 | Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry | Gastric Cancer | 2011 | 253 |
28 | Molecular-pathological prognostic factors of gastric cancer: a review | Gastric Cancer | 2005 | 242 |
29 | Imaging in assessing lymph node status in gastric cancer | Gastric Cancer | 2009 | 242 |
30 | Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification | Gastric Cancer | 2016 | 242 |
31 | Gastric cancer screening using the serum pepsinogen test method | Gastric Cancer | 2006 | 237 |
32 | Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer | Gastric Cancer | 1998 | 235 |
33 | Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry | Gastric Cancer | 2006 | 234 |
34 | Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer | Gastric Cancer | 2016 | 230 |
35 | Laparoscopic total gastrectomy with distal pancreatosplenectomy and D2 lymphadenectomy for advanced gastric cancer | Gastric Cancer | 1999 | 220 |
36 | Controlling Nutritional Status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection | Gastric Cancer | 2018 | 214 |
37 | Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: randomized, double-blind, phase III study (AVATAR study) | Gastric Cancer | 2015 | 209 |
38 | Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition) | Gastric Cancer | 2023 | 204 |
39 | DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer | Gastric Cancer | 2015 | 201 |
40 | Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination | Gastric Cancer | 2016 | 197 |
41 | Metachronous gastric cancers after endoscopic resection: how effective is annual endoscopic surveillance? | Gastric Cancer | 2006 | 193 |
42 | Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein–Barr virus status in a large cohort of gastric cancer patients | Gastric Cancer | 2017 | 189 |
43 | High rate of 5-year survival among patients with early gastric cancer undergoing curative endoscopic submucosal dissection | Gastric Cancer | 2016 | 185 |
44 | How useful is preoperative imaging for tumor, node, metastasis (TNM) staging of gastric cancer? A meta-analysis | Gastric Cancer | 2012 | 182 |
45 | Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study | Gastric Cancer | 2019 | 181 |
46 | Sarcopenia is associated with severe postoperative complications in elderly gastric cancer patients undergoing gastrectomy | Gastric Cancer | 2016 | 175 |
47 | Effectiveness of a preoperative exercise and nutritional support program for elderly sarcopenic patients with gastric cancer | Gastric Cancer | 2017 | 174 |
48 | Body composition assessment and sarcopenia in patients with gastric cancer: a systematic review and meta-analysis | Gastric Cancer | 2019 | 171 |
49 | Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis | Gastric Cancer | 2016 | 169 |
50 | Long-term quality-of-life comparison of total gastrectomy and proximal gastrectomy by Postgastrectomy Syndrome Assessment Scale (PGSAS-45): a nationwide multi-institutional study | Gastric Cancer | 2015 | 166 |